These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 21734420)

  • 21. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
    Ziol M; Sutton A; Calderaro J; Barget N; Aout M; Leroy V; Blanc JF; Sturm N; Bioulac-Sage P; Nahon P; Nault JC; Charnaux N; N'kontchou G; Trinchet JC; Delehedde M; Seror O; Beaugrand M; Vicaut E; Ganne-Carrié N
    J Hepatol; 2013 Dec; 59(6):1264-70. PubMed ID: 23928407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
    Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
    J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation.
    Sheng RF; Zeng MS; Ren ZG; Ye SL; Zhang L; Chen CZ
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):603-12. PubMed ID: 26663008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.
    Huang J; Hernandez-Alejandro R; Croome KP; Yan L; Wu H; Chen Z; Prasoon P; Zeng Y
    J Gastrointest Surg; 2011 Feb; 15(2):311-20. PubMed ID: 21052859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
    Tsuchiya K; Asahina Y; Tamaki N; Yasui Y; Hosokawa T; Ueda K; Nakanishi H; Itakura J; Kurosaki M; Enomoto N; Izumi N
    Liver Transpl; 2014 Mar; 20(3):291-7. PubMed ID: 24734314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.
    Cho HJ; Kim SS; Ahn SJ; Park SY; Park JH; Kim JK; Wang HJ; Cheong JY; Cho SW
    Cytokine; 2015 Jun; 73(2):245-52. PubMed ID: 25797190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
    Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
    Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic radiofrequency ablation of solitary small hepatocellular carcinoma in the caudate lobe.
    Jiang K; Zhang W; Su M; Liu Y; Zhao X; Wang J; Yao M; Ogbonna J; Dong J; Huang Z
    Eur J Surg Oncol; 2013 Nov; 39(11):1236-42. PubMed ID: 23993049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
    Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
    Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
    Peng ZW; Zhang YJ; Chen MS; Lin XJ; Liang HH; Shi M
    Eur J Surg Oncol; 2010 Nov; 36(11):1054-60. PubMed ID: 20846819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.
    Kim JS; Kim W; So YH; Yu SJ; Kim BG
    J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
    Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
    World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.
    Cho JY; Choi MS; Lee GS; Sohn W; Ahn J; Sinn DH; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW
    Clin Mol Hepatol; 2016 Dec; 22(4):477-486. PubMed ID: 28081587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.